Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population (July 2005)
8.184m
GDP (2004 - PPP basis)
€255.9bn
Health expenditure (2003)
Health expenditure as proportion of GDP (2003)
Size of pharmaceutical market (2003)
Percentage of health expenditure spent on pharmaceuticals (2002)
Proportion of GDP spent on pharmaceuticals (2002)
Pharmaceutical market growth rate (2003)
Local currency
Euro (€)
Summary: Austria
Austria is one of the few countries to insist on setting maximum prices based on economics, regardless of the type of product. Since 1999, most companies have signed agreements with the Federation of Social Insurers and Federal Economic Chamber which allows companies to simply notify price. In 2005 a new reimbursement system came into force reducing the lead time between marketing authorisation and reimbursement for new products.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
06/06/2005
Health funds sick of deficit
15/02/2004
Government encourages generics
Related Items




